Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Soyka

Showing results (21-30 of 150) with videos related to

Pageof 15
Sort By:
Pharmacopsychiatry|November 14, 2013
Opioids and traffic safety--focus on buprenorphineM Soyka
Der Nervenarzt|November 1, 1996
[Alcohol-induced hallucinosis. Clinical aspects, pathophysiology and therapy]M Soyka
Der Nervenarzt|June 8, 2014
[Driving ability with alcohol and drug dependence and schizophrenia]M Soyka, S Dittert, S Kagerer-Volk, et al.
Der Nervenarzt|September 4, 2015
[Emotion regulation and quality of life in consumption of cocaine and amphetamines : Results of an online survey]S Lehmberg, M Soyka
Alcohol and Alcoholism (Oxford, Oxfordshire). Supplement|January 1, 1994
Acamprosate: a new pharmacotherapeutic approach to relapse prevention in alcoholism--preliminary dataM Soyka, H Sass
Fortschritte Der Neurologie-Psychiatrie|April 12, 2002
[Aggressiveness in schizophrenia: prevalence, psychopathological and sociodemographic correlates]M Soyka, S Ufer
Pharmacopsychiatry|December 20, 2014
No evidence for development of tolerance after repeated use of propofol for electroconvulsive therapyM Soyka, W Fischer
Fortschritte Der Neurologie-Psychiatrie|June 1, 1992
[Compliance in therapy of schizophrenic patients with neuroleptics--an overview]C Mayer, M Soyka
Fortschritte Der Neurologie-Psychiatrie|March 5, 2005
[Catamnestic study on the efficacy of an intensive outpatient treatment programme for alcohol-dependent patients: impact of participation in AA on the abstinence rates]M Bottlender, M Soyka
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 9, 2008
Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendationsT Wobrock, M Soyka
Pageof 15

Showing results (21-30 of 150) with videos related to

Sort By:
Pageof 15
Pharmacopsychiatry|November 14, 2013
Opioids and traffic safety--focus on buprenorphineM Soyka
Der Nervenarzt|November 1, 1996
[Alcohol-induced hallucinosis. Clinical aspects, pathophysiology and therapy]M Soyka
Der Nervenarzt|June 8, 2014
[Driving ability with alcohol and drug dependence and schizophrenia]M Soyka, S Dittert, S Kagerer-Volk, et al.
Der Nervenarzt|September 4, 2015
[Emotion regulation and quality of life in consumption of cocaine and amphetamines : Results of an online survey]S Lehmberg, M Soyka
Alcohol and Alcoholism (Oxford, Oxfordshire). Supplement|January 1, 1994
Acamprosate: a new pharmacotherapeutic approach to relapse prevention in alcoholism--preliminary dataM Soyka, H Sass
Fortschritte Der Neurologie-Psychiatrie|April 12, 2002
[Aggressiveness in schizophrenia: prevalence, psychopathological and sociodemographic correlates]M Soyka, S Ufer
Pharmacopsychiatry|December 20, 2014
No evidence for development of tolerance after repeated use of propofol for electroconvulsive therapyM Soyka, W Fischer
Fortschritte Der Neurologie-Psychiatrie|June 1, 1992
[Compliance in therapy of schizophrenic patients with neuroleptics--an overview]C Mayer, M Soyka
Fortschritte Der Neurologie-Psychiatrie|March 5, 2005
[Catamnestic study on the efficacy of an intensive outpatient treatment programme for alcohol-dependent patients: impact of participation in AA on the abstinence rates]M Bottlender, M Soyka
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 9, 2008
Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendationsT Wobrock, M Soyka
Pageof 15